An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 30, 2013

Primary Completion Date

January 2, 2029

Study Completion Date

January 2, 2029

Conditions
Juvenile Idiopathic Arthritis
Trial Locations (59)

0

Local Institution - 0025, Bregenz

Local Institution - 0021, Cluj-Napoca

Local Institution - 0022, Piešťany

1

Local Institution - 0007, Lima

1160

Local Institution - 0032, Vienna

1600

Local Institution - 0020, Lisbon

2100

Local Institution - 0012, Copenhagen

7006

Local Institution - 0049, Trondheim

7500

Local Institution - 0057, Panorama, Cape Town

8200

Local Institution - 0035, Aarhus

9019

Local Institution - 0048, Tromsø

10117

Local Institution - 0030, Berlin

11426

Local Institution - 0024, Riyadh

16147

Local Institution - 0015, Genova

21159

Local Institution - 0055, Jeddah

22391

Local Institution - 0031, Hamburg

24576

Local Institution - 0003, Bad Bramstedt

28046

Local Institution - 0038, Madrid

30120

Local Institution - 0037, Murcia

31059

Local Institution - 0041, Toulouse

35128

Local Institution - 0044, Padua

38100

Local Institution - 0046, Trento

44620

Local Institution - 0006, Guadalajara

45229

Local Institution - 0059, Cincinnati

46009

Local Institution - 0039, Valencia

50139

Local Institution - 0042, Florence

54642

Local Institution - 0016, Thessaloniki

63000

Local Institution - 0040, Clermont-Ferrand

69120

Local Institution - 0033, Heidelberg

72202

Local Institution - 0060, Little Rock

75743

Local Institution - 0005, Paris

79106

Local Institution - 0034, Freiburg im Breisgau

80131

Local Institution - 0043, Naples

80138

Local Institution - 0045, Napoli

91031

Local Institution - 0014, Jerusalem

115522

Local Institution - 0051, Moscow

119991

Local Institution, Moscow

194100

Local Institution - 0053, Saint Petersburg

410054

Local Institution - 0052, Saratov

08540

Local Institution - 0001, Princeton

A-6020

Local Institution - 0002, Innsbruck

18618-970

Local Institution - 0010, Botucatu

13083-888

Local Institution - 0026, Campinas

04023-061

Local Institution - 0028, São Paulo

22250-110

Local Institution - 0027, Rio de Janeiro

T3B 6A8

Local Institution - 0029, Calgary

H4A 3J1

Local Institution - 0011, Montreal

H-1023

Local Institution - 0017, Budapest

LV-1007

Local Institution - 0018, Riga

3015 CE

Local Institution - 0047, Rotterdam

3584 EA

Local Institution - 0019, Utrecht

LIMA 14

Local Institution - 0050, Lima

PR 960

Local Institution - 0023, Bayamón

Local Institution - 0056, Bayamón

0002

Local Institution - 0009, Pretoria

0084

Local Institution - 0058, Pretoria

08970

Local Institution - 0036, Sant Joan Despí

08035

Local Institution - 0004, Barcelona

BS2 8BJ

Local Institution - 0013, Bristol

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01357668 - An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis | Biotech Hunter | Biotech Hunter